As of April 16, 2025, Opthea (OPT) has a market cap of $0.52 billion USD. According to our data, Opthea is ranked No.5909 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.52 B |
-13.18%
|
Dec 31, 2024 | $0.60 B |
33.15%
|
Dec 29, 2023 | $0.45 B |
-44.96%
|
Dec 30, 2022 | $0.82 B |
-28.96%
|
Dec 31, 2021 | $1.16 B |
-32.72%
|
Dec 31, 2020 | $1.73 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Alcon
ALC
|
$45.22 B |
-0.002 M
|
![]() Switzerland
|
![]() Adverum Biotechnologies
ADVM
|
$67.19 M |
-0.000 M
|
![]() USA
|
![]() Kodiak Sciences
KOD
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Outlook Therapeutics
OTLK
|
$45.34 M |
-0.000 M
|
![]() USA
|
![]() Ocular Therapeutix
OCUL
|
$1.20 B |
-0.000 M
|
![]() USA
|
![]() EyePoint Pharmaceuticals
EYPT
|
$0.39 B |
-0.000 M
|
![]() USA
|
![]() Clearside Biomedical
CLSD
|
$63.40 M |
0.000 M
|
![]() USA
|
![]() Aldeyra Therapeutics
ALDX
|
$0.13 B |
0.000 M
|
![]() USA
|
Market Cap | = | OPT Stock Price | * | OPT Shares Outstanding |
= | $3.41 | * | 0.15 B | |
= | $0.52 B |